Cargando…
The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta
OBJECTIVE: Our objective was to describe the costs of industry-sponsored clinical trials for medical devices in Northern Alberta, Canada. METHODS: We used centralized data to identify all industry-sponsored medical device clinical trials initiated in Northern Alberta from 2012 to 2016. For each arm...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861404/ https://www.ncbi.nlm.nih.gov/pubmed/31037645 http://dx.doi.org/10.1007/s41669-019-0137-0 |
_version_ | 1783471349279227904 |
---|---|
author | Akpinar, Ilke Ohinmaa, Arto Thording, Lars Tran, Dat T. Fedorak, Richard N. Richer, Lawrence Jacobs, Philip |
author_facet | Akpinar, Ilke Ohinmaa, Arto Thording, Lars Tran, Dat T. Fedorak, Richard N. Richer, Lawrence Jacobs, Philip |
author_sort | Akpinar, Ilke |
collection | PubMed |
description | OBJECTIVE: Our objective was to describe the costs of industry-sponsored clinical trials for medical devices in Northern Alberta, Canada. METHODS: We used centralized data to identify all industry-sponsored medical device clinical trials initiated in Northern Alberta from 2012 to 2016. For each arm of each trial, we calculated the price of devices provided by the sponsor and the cost of clinical and administrative services that were incurred to clinically operationalize the treatment. RESULTS: Our sample consisted of 18 device trials initiated between January 2012 and January 2016. The overall cost (Canadian dollars [$Can], year 2018 values) per enrolee was $Can18,243 for the experimental arm and $Can13,827 for the control arm. Devices were the highest cost component, at $Can13,446 per enrollee in the experimental arm. Clinical costs in the control arms were higher on average ($Can7202 vs. 2504) than those in the experimental arms. CONCLUSION: Data from industry-sponsored clinical trials can provide important information on the full costs of device-related interventions. As device costs rise, and as policy makers require more evidence on device-related treatments, the cost of medical device-driven interventions should be documented along with their effectiveness. |
format | Online Article Text |
id | pubmed-6861404 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-68614042019-12-03 The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta Akpinar, Ilke Ohinmaa, Arto Thording, Lars Tran, Dat T. Fedorak, Richard N. Richer, Lawrence Jacobs, Philip Pharmacoecon Open Original Research Article OBJECTIVE: Our objective was to describe the costs of industry-sponsored clinical trials for medical devices in Northern Alberta, Canada. METHODS: We used centralized data to identify all industry-sponsored medical device clinical trials initiated in Northern Alberta from 2012 to 2016. For each arm of each trial, we calculated the price of devices provided by the sponsor and the cost of clinical and administrative services that were incurred to clinically operationalize the treatment. RESULTS: Our sample consisted of 18 device trials initiated between January 2012 and January 2016. The overall cost (Canadian dollars [$Can], year 2018 values) per enrolee was $Can18,243 for the experimental arm and $Can13,827 for the control arm. Devices were the highest cost component, at $Can13,446 per enrollee in the experimental arm. Clinical costs in the control arms were higher on average ($Can7202 vs. 2504) than those in the experimental arms. CONCLUSION: Data from industry-sponsored clinical trials can provide important information on the full costs of device-related interventions. As device costs rise, and as policy makers require more evidence on device-related treatments, the cost of medical device-driven interventions should be documented along with their effectiveness. Springer International Publishing 2019-04-29 /pmc/articles/PMC6861404/ /pubmed/31037645 http://dx.doi.org/10.1007/s41669-019-0137-0 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Research Article Akpinar, Ilke Ohinmaa, Arto Thording, Lars Tran, Dat T. Fedorak, Richard N. Richer, Lawrence Jacobs, Philip The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta |
title | The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta |
title_full | The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta |
title_fullStr | The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta |
title_full_unstemmed | The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta |
title_short | The Costs of Industry-Sponsored Medical Device Clinical Trials in Alberta |
title_sort | costs of industry-sponsored medical device clinical trials in alberta |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6861404/ https://www.ncbi.nlm.nih.gov/pubmed/31037645 http://dx.doi.org/10.1007/s41669-019-0137-0 |
work_keys_str_mv | AT akpinarilke thecostsofindustrysponsoredmedicaldeviceclinicaltrialsinalberta AT ohinmaaarto thecostsofindustrysponsoredmedicaldeviceclinicaltrialsinalberta AT thordinglars thecostsofindustrysponsoredmedicaldeviceclinicaltrialsinalberta AT trandatt thecostsofindustrysponsoredmedicaldeviceclinicaltrialsinalberta AT fedorakrichardn thecostsofindustrysponsoredmedicaldeviceclinicaltrialsinalberta AT richerlawrence thecostsofindustrysponsoredmedicaldeviceclinicaltrialsinalberta AT jacobsphilip thecostsofindustrysponsoredmedicaldeviceclinicaltrialsinalberta AT akpinarilke costsofindustrysponsoredmedicaldeviceclinicaltrialsinalberta AT ohinmaaarto costsofindustrysponsoredmedicaldeviceclinicaltrialsinalberta AT thordinglars costsofindustrysponsoredmedicaldeviceclinicaltrialsinalberta AT trandatt costsofindustrysponsoredmedicaldeviceclinicaltrialsinalberta AT fedorakrichardn costsofindustrysponsoredmedicaldeviceclinicaltrialsinalberta AT richerlawrence costsofindustrysponsoredmedicaldeviceclinicaltrialsinalberta AT jacobsphilip costsofindustrysponsoredmedicaldeviceclinicaltrialsinalberta |